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Abstract Type 2 diabetes is a chronic disease that is increas-
ing in prevalence globally. Cardiovascular disease is a major
cause of mortality and morbidity in diabetes, and lifestyle and
clinical risk factors do not fully account for the link between
the conditions. This article provides an overview of the evi-
dence concerning the role of psychosocial stress factors in
diabetes risk, as well as in cardiovascular complications in
people with existing diabetes. Several types of psychosocial
factors are discussed including depression, other types of
emotional distress, exposure to stressful conditions, and per-
sonality traits. The potential behavioral and biological path-
ways linking psychosocial factors to diabetes are presented
and implications for patient care are highlighted.
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Introduction
Diabetes is a growing problem that poses a major public
health challenge globally. According to reports by the
International Diabetes Federation (IDF) and the World
Health Organization (WHO), over 8 % of the world
population (415–420 million people) currently have diabetes,
with prevalence expected to rise to 10.4 % (642 million) by
2040 [1, 2]. In the USA, an estimated 9.3 % of the population
(29.1 million people) have diabetes [3]. Worldwide, type 2
diabetes is the most common form of diabetes accounting
for 90 % of cases [1, 4]. Throughout this review, the term
Bdiabetes^ will be used to refer to type 2 diabetes unless indi-
cated otherwise.
Diabetes is the fourth or fifth leading cause of mortality in
most high-income countries and as such represents a signifi-
cant burden to public health systems [5]. In 2015, health
spending on diabetes represented 12 % (USD 673 billion) of
global health expenditure and it may account for up to 20% of
national health-care budgets in some countries [1].
Additionally, the indirect costs of diabetes such as a
reduced labor force and lowered economic productivity
are considerable [6].
Cardiovascular Disease in People with Diabetes
Cardiovascular disease (CVD) is a major cause of mortality
and morbidity in individuals with diabetes. Results from a
meta-analysis of 102 prospective studies indicate that people
with diabetes have a 2-fold excess risk of CVD compared with
controls. This association is independent of traditional CVD
risk factors [7]. The risk associated with raised blood glucose
is continuous, such that intermediate categories of glucose
disturbance or Bprediabetes^ are associated with heightened
CVD risk [7, 8]. Contemporary evidence from a longitudinal
population study of 1.9 million people provides more evi-
dence that there is a strong association between diabetes and
incident CVD [9]; however, it is worth noting that the magni-
tude of the reported relationship varied between different
CVD subtypes in this study.
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In keeping with wider population time trends, CVD rates
have fallen over the past decades among people with diabetes
[10]. However, the reduction has been less than in the rest of
the population; thus, the heightened risk of CVD in people
with diabetes persists [11•, 12].
In addition to heightened CVD risk, diabetes is associated
with CVD mortality. According to a review of 97 prospective
studies, individuals with diabetes die 6 years earlier on aver-
age than their counterparts without the condition, and approx-
imately 58 % of this survival difference is attributable to ex-
cess vascular deaths [13]. Similar estimates of CVD-driven
excess mortality are presented in the latest IDF and WHO
reports [1, 2]. In an authoritative pooled analysis of 91 longi-
tudinal cohort studies, diabetes, stroke, and MI were found to
have equivalent associations with all-cause mortality [14].
Outcomes following a cardiovascular event are substantial-
ly worse in people with diabetes. In a trial of 13,608 ST-
segment elevation MI patients, participants with diabetes
had significantly higher rates of recurrent nonfatal MI and
cardiovascular death than patients without diabetes [15].
Interestingly, diabetes is approximately a third more strongly
related to fatal than nonfatal MI [13]. Similarly, in individuals
with heart failure, diabetes is an independent predictor of re-
peat hospitalization and cardiac death [16]. Diabetes increases
the risk of recurrent stroke [17] and attenuates both cognitive
and functional recovery [18]. Myocardial revascularization
procedures are also challenging in individuals with diabetes;
compared to patients without the condition, people with dia-
betes have a substantially increased risk of mortality and ad-
verse clinical outcomes following these procedures [19, 20].
CVD and Diabetes: A Link Beyond Traditional Risk
Factors
Lifestyle factors (smoking, poor diet, physical inactivity, ex-
cess alcohol consumption), clinical factors (obesity, hyperten-
sion, raised cholesterol), and psychosocial stress have been
identified as modifiable risk factors for CVD development
[5, 21]. Psychosocial stress factors can be divided into nega-
tive emotional disorders (e.g., depression and anxiety), per-
sonal traits (e.g., anger or hostility), and external stressors
(exposure to stressful conditions). The evidence relating
sociodemographic, behavioral, and clinical risk factors with
CVD risk in people with diabetes was reviewed in this journal
in 2015 [22]. This article did not cover the role of psychosocial
factors in diabetes and their association with CVD risk.
Furthermore, there is evidence that the link between CVD
and diabetes is not fully accounted for by traditional risk fac-
tors. In meta-analyses showing greatly increased CVD mor-
bidity and mortality in diabetes, the reported associations were
robust to adjustment for clinical and behavioral risk factors [7,
13]. With regards to intervention and prevention, intensive
programs targeting lifestyle factors such as diet, physical ac-
tivity, and weight management have been shown to prevent
diabetes onset in people with and without prediabetes
[23–25]. The Diabetes Prevention Programs are recognized
as some of the most effective lifestyle interventions for
preventing chronic disease. Since these interventions modify
CVD risk factors such high bodymass index (BMI) and blood
pressure [26], they in turn should have an impact on CVD
outcomes. However, lifestyle interventions to reduce CVD
in people with diabetes have been largely disappointing.
These trial results were reviewed in 2015 in a joint report from
the American Heart Association and American Diabetes
Association [11•]. Evidence from prospective intervention
studies such as the LookAHEAD trial [26] and the
ACCORD trial [27, 28] suggests that the modification of be-
havioral risk factors such as weight loss, blood pressure, and
cholesterol control does not significantly lower risk of adverse
CVD outcomes in people with diabetes. Another survey of
nearly 100 studies that looked at physical activity interven-
tions and subsequent CVD in people with diabetes concluded
that although effects have been seen in small studies, large
randomized control trials (RCTs) have not found a protective
effect [29]. Some positive findings regarding diet have been
reported in the Spanish PREDIMED RCT. This study found
that participants with diabetes who were randomized to a
Mediterranean diet had a 30 % reduced risk of CVD over
4.8 years of follow-up [30]. However, these results must be
interpreted with caution as a similar effect of dietary change
on CVD outcomes were not reported in the LookAHEAD trial
or the Diabetes Prevention Programs [23–25]. It may be that
the Mediterranean diet is superior to the low-calorie diet used
in other trials, but further studies are required to test this
assertion.
In light of this evidence, it appears that increased risk of
CVD in people with diabetes is not fully explained by tradi-
tional risk factors. Therefore, the current review focuses on
psychosocial factors in diabetes. Specifically, we evaluate the
role of psychosocial factors in diabetes development, as well
as the evidence for the involvement of psychosocial factors
translating diabetes into increased CVD risk.
Psychosocial Factors in Cardiovascular Disease
There is accumulating evidence that psychosocial stress plays
a role in the pathogenesis of CVD [31, 32, 33•]. Numerous
systematic reviews and prospective analyses [34, 35] are in
agreement that chronic stressors and psychosocial factors pre-
dict future coronary heart disease in initially healthy popula-
tions independently of standard risk factors. Considering the
strong links between CVD and diabetes, it is not surprising
that there has been interest in investigating whether psycho-
social stress plays a role in diabetes and whether this is related
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to CVD risk in this population. The following sections review
evidence from prospective studies that have examined the
links between different psychosocial stress factors and
diabetes.
The conceptual framework in Fig. 1 indicates that psycho-
social factors potentially impact on diabetes and cardiovascu-
lar risk in several ways: (1) influencing lifestyle risk factors for
diabetes such as adiposity and physical activity, (2) affecting
the development of diabetes directly through mechanisms
such as glucose dysregulation and inflammation, and (3) shap-
ing the processes through which diabetes stimulates cardio-
vascular complications. These distinctions are important both
in etiological understanding and because of their implications
for disease management.
Psychosocial Factors and Diabetes Risk
Emotional Distress
Depression is the most commonly researched factor in studies
of diabetes. Results from two meta-analyses of longitudinal
studies indicate that depression is associated with 37–60 %
increased risk of developing diabetes [36, 37]. Prospective
evidence also suggests that elevated depressive symptoms,
as well as clinical depression, are related to subsequent inci-
dence of diabetes [38, 39]. The associations reported in these
studies remained significant after controlling for diabetes risk
factors such as BMI, family history of diabetes, smoking,
physical activity, diet, and alcohol consumption.
It should be emphasized that these studies do not prove
causality, and alternative noncausal explanations are plausible
[40•]. One possibility is that diabetes and depression share
common etiological factors such as physical inactivity or in-
flammation that may not be completely eliminated by statisti-
cal adjustments. Alternatively, preclinical diabetes may in-
crease the chances that an individual reports depression,
resulting in a reverse causal process that is detailed later in
this review.
Fewer studies have investigated whether anxiety is associ-
ated with diabetes development. Engum [41] investigated the
association in a Norwegian population cohort of 37,291 peo-
ple. Over a 10-year follow-up, individuals who reported
symptoms of anxiety at baseline had an increased risk of de-
veloping diabetes (odds ratio (OR) = 1.5; 95 % confidence
interval (CI) 1.3–1.8) [41]. A limitation of this study was that
anxiety and depression symptoms were not investigated sep-
arately; therefore, the effect of anxiety on diabetes indepen-
dent of depression could not be assessed. A similar association
between anxiety alone and incident diabetes (OR = 1.6; 95 %
CI 1.2–2.1) was found in the Netherlands Study of Depression
and Anxiety (NESDA) [42]. However, not all longitudinal
research has found an association between anxiety and subse-
quent diabetes [43, 44], and there may be sex differences that
are poorly understood [45, 46].
Psychological distress encompasses a range of comorbid
psychological factors, such as depressive and anxiety symp-
toms, general stress as well as sleep disturbance. In a UK
study of 9514 people, psychological distress at baseline was
associated with incident diabetes over 18 years of follow-up
adjusting for age, sex, education, and income. However, the
relationship did not remain significant after additional adjust-
ment for health-related factors [47]. In the UK Whitehall II
cohort, psychological distress did not predict diabetes in the
overall sample, but in a subsample of participants at high risk
of diabetes (prediabetes at baseline and >40 on the
Framingham diabetes risk score), distress was associated with
a 40.9 % increased risk of diabetes independent of a range of
covariates [48]. No sex interaction effects were found in the
UK studies, but an earlier Swedish study of 5227 individuals
who were normoglycemic at baseline reported an association
between distress and subsequent diabetes in male but not in
female participants [49]. The reasons for the mixed findings in
the studies are unclear. It may be that initial health moderates
the relationship and psychological distress accelerates pro-
gression to diabetes only in high-risk individuals. Another
issue is that distress in of itself may be too broad a measure
and that only particular aspects of it are related to future
diabetes.
Exposure to Life Stress
Chronic exposure to external stressors has also been implicated
in diabetes onset. To date, the majority of research has explored
the relationship between work stress and incident diabetes [50,
51••]. Job strain, which is the combination of high job demands
and low control at work, is a widely studied work stress con-
struct [52]. A large meta-analysis investigating the link between
job strain and diabetes development pooled results from 13
prospective European cohort studies. Over a mean follow-up
of 10.3 years, job strain was associated with a 1.15-fold (95 %
CI 1.06–1.25) increased risk of incident diabetes [51••]. This
association was independent of a range of covariates and ex-
tends previous pooled cross-sectional associations [53]. AFig. 1 Conceptual framework
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substantial number of studies of the relationship between long
work hours and diabetes have also been carried out [50]. It
appears that that working 55 h or more a week also increases
the risk of developing diabetes but only in low socioeconomic
status (SES) groups (RR 1.29, 95 % CI 1.06–1.57).
Perceived stress is a broader conceptualization of psycho-
social stress exposure that has been implicated in diabetes
development. Novak et al. [54] investigated the relationship
between perceived permanent stress (self-reported stress
related to work or home life that was ongoing for a year or
more) and incident diabetes in a sample of 7251men. Over the
35-year follow-up period, men with permanent stress had a
greatly increased risk of diabetes (HR 1.52; 95 % CI 1.26–
1.82) compared with those reporting no or periodic stress.
This relationship was not accounted for by conventional dia-
betes risk factors. Similarly, Japanese men with high levels of
Bstress in daily life^ have been found to have a greater risk of
incident diabetes over a 3-year follow-up [55].
However, findings from other prospective studies with both
male and female participants have been equivocal. In the
Copenhagen City Heart Study involving 7066 participants,
men who reported daily emotional stress were two times more
likely to develop diabetes than those with low levels of stress
over a 10-year follow-up period (OR = 2.36; 95 % CI 1.22–
4.59), but no associations were found for women [56].
Conversely, a study of 3759Australian men andwomen found
no relationship between perceived stress and the development
of abnormal glucose tolerance in men over 5 years of follow-
up, but detected an association in women [57]. It is unclear
why some studies have found sex differences, but sample size
might offer one possible explanation. The largest study to date
investigated the relationship between perceived stress and
subsequent diabetes development in 55,826 Japanese men
and women over a 10-year follow-up period [58]. In this anal-
ysis, high levels of perceived stress were found to increase the
risk of diabetes onset in both men and women, but effects
were stronger amongmale (OR 1.39; 95%CI 1.15–1.65) than
female participants (OR 1.25; 95 % CI 1.01–1.56) after ad-
justment for known diabetes risk factors.
Another study assessed the association between perceived
stress and diabetes in 22,567 participants (71 % men) from a
French workforce cohort. Over 5.3 years of follow-up, no
association between perceived stress and future diabetes was
observed in the full sample [59]. However, perceived stress
was significantly associated with new onset diabetes in partic-
ipants of low occupational status (OR 1.39; 95 % CI 1.02–
1.90). The authors suggest that low occupational status might
reflect a greater work stress. If this is the case, these results
would map onto previous meta-analytic findings indicating
that long working hours are only associated with incident
diabetes in those of low SES [50].
Considering the current evidence as a whole, there appears
to be an association between perceived stress and increased
risk of diabetes in initially healthy populations. However, sex
or SES (as measured by occupational status) may moderate
this association. As in the case of depression, these longitudi-
nal observational studies do not prove causality.
Early Life Adversity
Early life adversity has not been widely investigated as a risk
factor for future diabetes onset, though it appears to be a sig-
nificant issue for health-related processes such as telomere
length and inflammation in adult life [60, 61]. A review pub-
lished in 2015 summarized the existing evidence on diabetes
[62•], analyzing 7 prospective and cross-sectional studies with
data on 87,251 participants. People who reported an adverse
childhood experience had a 32 % increased odds of diabetes.
Looking at different types of childhood stress, the strongest
association was found for neglect (OR 1.92), followed by
sexual abuse (OR 1.39) and physical abuse (OR 1.30). A
limitation of this meta-analysis is that some of the studies
included involved retrospective accounts of childhood adver-
sity which may not be accurate, whereas other studies were
analyses of life course data. The studies varied in diabetes
measurement, with both self-reported and objective measures
being used. There are unanswered questions in this area such
as whether there is a critical period in exposure to early life
stress or whether there is a dose-response relationship between
the frequency or duration of the stress and diabetes risk.
Prenatal stress has also been suggested to play a role in the
development of diabetes. In a large Danish cohort study, par-
ticipants who were exposed to prenatal stress (n = 45,302 out
of nearly 1.9 million) because their mothers experienced be-
reavement in their prenatal life were found to have an elevated
risk of future diabetes (incidence rate ratio 1.31; 95 % CI
1.01–1.69). This association was independent of parental dia-
betes and other conventional diabetes risk factors [63].
Personality Traits
Personality factors are not well researched in relation to dia-
betes. Hostility is a trait that is typically conceptualized as a
negative cynical attitude toward others, with a propensity for
anger or aggression [64]. This trait has been associated pro-
spectively with raised fasting glucose [65] and cross-
sectionally with insulin resistance [66, 67], glycated hemoglo-
bin (HbA1c) [67, 68], and prevalent diabetes [69].
Additionally, angry temperament has been investigated in re-
lation to diabetes development. In a cohort study of 11,615
individuals who were disease-free at baseline, individuals
with an angry temperament had a 1.34 increased hazard of
incident diabetes over the 6-year follow-up period [70]. This
association has also been investigated in the MESA cohort
[43] with a smaller sample size of 5598 participants but a
longer follow-up of 11.4 years. Participants reporting high
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levels of trait anger at baseline had a 48 % greater risk of
developing diabetes than those with low anger (HR 1.48;
95 % CI 1.04–2.12) independent of demographic factors, ex-
ercise, diet, alcohol use, and smoking. However, the associa-
tion was attenuated following adjustment for waist circumfer-
ence. So although there have not been many studies investi-
gating anger and hostility, the current evidence suggests that
these characteristics may also be associated with an increased
risk of diabetes in later life.
Potentially Protective Psychosocial Factors
The vast majority of work has investigated relationships be-
tween negative psychosocial stress factors and future diabetes.
To our knowledge, only two studies have investigated associ-
ations with potentially protective positive factors. Crump et al.
studied the relationship between resilience to stress in adoles-
cence and diabetes in later life [71••]. The study used an im-
pressive sample of over 1.5 million Swedish military con-
scripts who were assessed for stress resilience during a
semistructured interview at 18 years. The participants were
followed up for an average of 25.7 years using national med-
ical records. Participants with the lowest stress resilience had a
51 % increased hazard of future diabetes compared to those
with high levels of resilience (HR 1.51; 95 % CI 1.46–1.57)
independent of a range of diabetes risk factors. These findings
suggest that personal resilience to stress might be an important
factor in the development of diabetes. The other study looked
at life satisfaction, emotional vitality, and optimism in 7800
individuals from theWhitehall II cohort [72]. Over 13 years of
follow-up, these well-being factors were not associated with
incident diabetes as assessed by self-reported and glucose tol-
erance testing. The authors performed subanalyses to assess
whether associations varied by type of diabetes diagnosis.
Individuals with high life satisfaction (OR = 0.85; 95 %
CI = 0.76–0.95) and emotional vitality (OR = 0.86; 95 %
CI = 0.77–0.97) were less likely to report doctor-diagnosed
diabetes. It is uncertain why associations differed for doctor-
diagnosed and screen-detected diabetes.
Psychosocial Factors and Cardiovascular
Complications in People with Diabetes
The research detailed in previous sections had primarily fo-
cused on pathway 2 outlined in Fig. 1. Additionally, psycho-
social factors may be relevant to the risk of cardiovascular
complications in people with diabetes (pathway 3).
Depression in Diabetes
Depression is common in people with diabetes [73–76]. A
meta-analysis of 10 studies with 51,331 individuals estimated
the prevalence of depression to be almost doubled in people
with diabetes compared to those without the condition (17.6
vs. 9.8 %; OR = 1.6; 95 % CI 1.2–2.0) [75]. The vast majority
of the studies have been conducted inWestern countries, but a
study of 213,797 people in 47 countries from around the
world has shown that people with diabetes had a 2-fold greater
prevalence of depressive symptoms than those without diabe-
tes (OR 2.36; 95 % CI 1.91–2.92) [73].
As well as increased prevalence in people with diabetes,
longitudinal studies indicate that diabetes diagnosis is a risk
factor for incident depression [37, 77, 78]. An analysis pooling
data from 16 longitudinal studies involving 497,223 participants
with an average follow-up of 5.8 years indicated that people
with diabetes have a 25 % increased risk of developing depres-
sion compared with controls without diabetes [78]. More recent
longitudinal studies have confirmed this relationship. For exam-
ple, an analysis of the English Longitudinal Study of Aging
(ELSA) cohort found that diabetes was associated with a dou-
bling in the odds of depressive symptoms over 4 years of
follow-up [42], while a larger study of 37,043 Swedish twins
with diabetes showed 33 % increased risk of major depression
[41]. However, in both of these studies, the association was only
found in younger participants with diabetes (≤55 or 64) and not
in older individuals. The reasons are not known. It might be that
middle-aged people with diabetes perceive their condition as a
disease of old age that should not have happened to them and
become more despondent following diagnosis. Alternatively, it
could be that younger patients have more competing priorities
(e.g., employment, raising children, and financial commitments
such as mortgages) and find diabetes care a greater burden to
manage in comparisonwith older patients who are likely to have
a grown-up family and be retired. There is some evidence from
smaller cross-sectional studies that diabetes management might
be more challenging for younger than older adults [79, 80] but
stronger prospective evidence from larger samples is required to
explore these possibilities further.
It should be pointed out that the link between depression
and diabetes is not unique to this condition. Similar associa-
tions have been observed for other common diseases such as
osteoarthritis, coronary heart disease, chronic lung diseases,
and stroke [81, 82]. Nevertheless, comorbid depression in
diabetes is a considerable threat to quality of life in people
with diabetes [83, 84] and is of clinical importance since it
has been associated with suboptimal glycemic control [85, 86]
and nonadherence to treatment regimens [87, 88], as well as
with the microvascular [89, 90] and macrovascular complica-
tions of diabetes. This review focuses on the risk of
macrovascular complications.
Depression and Complications
An increasing body of literature indicates that depression ex-
acerbates the risk of macrovascular complications in people
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with diabetes. Prospective studies have found a relationship
between comorbid depression and CVD in diabetes samples
[91, 92]. For instance, in the Pathways Epidemiological
Follow-up Study of over 4000 participants with diabetes, in-
dividuals with depression had a 24% increased risk of adverse
macrovascular complications including MI, stroke, cardiovas-
cular procedures, and cardiac death over 5 years of follow-up
[92]. This association was independent of prior complications,
sociodemographic characteristics, health behaviors, and dia-
betes self-care variables. Another study followed a cohort of
345,949 individuals who were free of CVD at baseline over a
7-year period. Results showed that participants with diabetes
alone and those with major depression alone had a 30 % in-
creased risk of MI, whereas those with a double diagnosis
(both diabetes and major depression) had an 82 % ex-
cess risk of subsequent MI compared to participants
without either condition [93].
Another study published in 2016 examined the association
between depressive symptoms or perceived stress at baseline
and risk of CVD in 22,003US adults [94]. Over almost 6 years
of follow-up, people with diabetes who reported elevated de-
pressive symptoms or perceived stress had a significantly in-
creased incidence of stroke (HR 1.57; 95% CI 1.05–2.33) and
acute CVD (HR 1.57; 95 % CI 1.02–2.40). These associations
were independent of demographics factors but were attenuat-
ed when controlling for lifestyle factors. The majority of stud-
ies have focused on white samples in Western countries. To
address this issue, Ting et al. [95•] conducted a 7.4-year
follow-up study in a sample of 7835 Chinese patients with
diabetes who were free of CVD at baseline. In this sample,
diagnosed depression predicted CVD [HR = 2.18] and the ma-
jority of the risk appeared to be driven by stroke [HR = 3.55].
The reported associations remained significant after adjust-
ment for a wide range of conventional CVD risk factors.
As might be expected from these findings, people with
both depression and diabetes have greater CVD mortality as
well as morbidity rates. An analysis of 16 prospective studies
indicated that comorbid depression in diabetes is associated
with a 39 % increased risk of cardiovascular death and a 46 %
higher risk of all-cause mortality [97].
Anxiety in Diabetes
In comparison with the research on comorbid depression,
there is relatively little research on other psychosocial factors
and their relationship to CVD risk in people with diabetes.
However, there is some evidence that the prevalence of other
psychosocial disorders is elevated in people with diabetes in
comparison with the general population. Overviews of this
research suggest that diabetes is associated with 20 % in-
creased odds of having an anxiety disorder and 48% increased
odds of having elevated anxiety symptoms [96]. Comorbid
anxiety is of clinical relevance to people with diabetes. An
association between anxiety and glycemic control has also
been reported in a number of studies [97], but to our knowl-
edge, only one study to date has investigated the prospective
relationship between anxiety and diabetes complications such
as retinopathy, neuropathy, or CVD, and no associations were
found [44]. However, the number of cases of diabetes and
anxiety was limited in this study, so it may have been
unpowered to detect such effects.
Psychological Distress and Diabetes-Specific Distress
Psychological distress has been linked with CVD morbidity
and increased mortality rates in people with diabetes. In a
study of 1533 individuals with diagnosed diabetes, distressed
participants were found to have a 1.69 increased hazard of a
CVD event and a 1.76-fold greater mortality rate compared to
individuals without psychological distress over an average
follow-up of 5.4 years [98]. This association was independent
of CVD risk factors, and excluding participants who were
receiving antidepressive treatment did not impact the results.
It would be interesting in future studies to tease out what
particular aspects of psychological distress are most strongly
linked to CVD.
As well as depression, anxiety, and general psychological
distress, diabetes-related emotional distress, a stress condition
specifically resulting from concerns and worries about diabe-
tes and its management, is common in people with diabetes
[99]. According to estimates from a study of 8596 adults with
diabetes from 17 countries, 44.6 % of patients suffer from
significant diabetes-related distress [100]. Diabetes-related
distress is of clinical significance, since several longitudinal
studies suggest that it is associated with poor glycemic control
independently of depression [99, 101, 102]. No studies to date
have investigated the association between diabetes-distress
and macrovascular complications.
Pathways Linking Psychosocial Factors
and Diabetes
The precise mechanisms linking psychosocial factors and di-
abetes remain to be elucidated. However, several potentially
interrelated pathways that plausibly account for the link have
been proposed. As noted in Fig. 1, one possibility is that the
adverse relationship between psychosocial factors and diabe-
tes may be mediated via behavioral pathways. Behavioral
mechanisms include poor diet, physical inactivity, excess al-
cohol consumption, and smoking. Reduced adherence to self-
care behaviors and cardioprotectivemedications such as blood
pressure and lipid-lowering drugs could also play a role.
Several lines of research support this mechanism.
Comorbid depression in diabetes increases nonadherence to
a range of behaviors including diet, medication usage, and
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exercise [87, 88]. For example, a study of 2759 individuals
with diabetes found that participants with persistent or increas-
ing depression symptoms had significantly poorer adherence
to dietary and exercise regimens than their counterparts with-
out depression over a 5-year follow-up period [88]. A cross-
sectional study with a similar sample size of 2646 individuals
with diabetes reported that physical inactivity doubled in the
presence of depressive symptoms [103]. Considerably less
research has investigated the behavioral pathways
linking other psychosocial factors and diabetes. The
Copenhagen City Heart Study of 7066 adults found that
perceived stress was associated with physical inactivity
and unsuccessful smoking cessation or alcohol reduction
attempts over a 10-year follow-up as well as the devel-
opment of overt diabetes among men [56].
Negative psychosocial factors that are common in diabetes
may also decrease motivation for healthy lifestyle choices that
in turn impact CVD risk. However, the association between
diabetes and CVD is not fully explained by behavioral risk
factors [7, 13], and results from RCTs suggest that the modi-
fication of behavioral risk factors does not significantly lower
CVD outcomes in people with diabetes, despite the fact that
lifestyle change has a marked effect on diabetes incidence
[11•]. This offers the possibility that a direct biological path-
way could link psychosocial factors with CVD risk in people
with diabetes.
Several different psychobiological mechanisms could link
psychosocial factors with both CVD and diabetes.
Depression, anxiety, and diabetes-related distress are associat-
ed with suboptimal glycemic control [85, 86, 97, 102, 104],
and there is evidence that the risk of CVD increases in line
with the degree of hyperglycemia [7, 105]. Long-term expo-
sure to psychosocial stress factors can result in chronic
allostatic load which involves dysregulation of multiple bio-
logical systems including neuroendocrine, cardiovascular,
metabolic, and inflammatory pathways [106]. Cross-
sectional evidence suggests that people with diabetes demon-
strate characteristics of high allostatic load in response to a
stressful experience [107•]. Evidence from the same sample
suggests that hostility (a psychosocial stress factor) can further
exaggerate the disturbances in stress-related processes in peo-
ple with diabetes [108].
Many of the different pathways involved in stress-related
allostatic load have been linked with both diabetes and CVD.
Dysregulation of the stress hormone cortisol is associated with
both acute and chronic stress factors [109], and prospective
evidence has linked changes in daily cortisol secretion with
CVD mortality [110], as well as new onset diabetes [111].
Another potential biological mechanism linking psychosocial
factors to both CVD and diabetes is inflammation. Elevated
inflammatory cytokine concentrations are observed in people
reporting high levels of psychosocial stress [112]. Both diabe-
tes [113] and CVD have been characterized as inflammatory
conditions [114]. In initially healthy populations, heightened
inflammatory cytokines levels have been associated with new
onset CVD [115], and it is plausible that raised cytokine levels
could increase the risk of CVD in diabetes populations, too.
The complexity of the link between psychosocial factors
and CVD risk in people with diabetes is reflected in the nu-
merous pathways that may be involved. It is likely that the
proposed behavioral and biological pathways do not act in
isolation but rather that they are interrelated. For example,
depression in diabetes might impact complications through
poorer adherence to diet and exercise regimes. Future research
in this area may benefit from investigating the synergies be-
tween behavioral and biological pathways in linking psycho-
social factors to CVD risk in people with diabetes.
Implications for Patient Care
Lifestyle interventions to prevent diabetes have been success-
ful [23–26]. However, interventions to modify behavioral risk
factors to prevent CVD in people with diabetes have been
largely disappointing. This poses the question whether modi-
fying psychosocial stress, another risk factor for CVD, would
have a therapeutic impact.
To date, the majority of research in this area has investigat-
ed whether the treatment of depression in diabetes is benefi-
cial. A Cochrane review in 2012 included 19 RCTs investi-
gating both psychological and pharmacological interventions
for depression in patients with diabetes [116]. Psychological
intervention studies showed a beneficial effect on short-, me-
dium-, and long-term depression severity and had a good im-
pact on depression remission compared to usual care.
However, the effect of psychological intervention on glycemic
control was mixed and inconclusive. With regards to the phar-
macological interventions, there was a moderate effect of an-
tidepressant medication on short-term depression severity and
depression remission, and interestingly, the pharmacological
trials significantly improved glycemic control in the short term
as well. But no study to date has assessed the relationship
between depression treatment and glycemic control in the lon-
ger term. Taking the evidence together, it appears that depres-
sion treatment is moderately effective in diabetes, but only
pharmacological trials have shown a consistent improvement
in glycemic control.
Mindfulness-based interventions for modifying psychoso-
cial stress factors have also been tested in people with diabetes
[117•]. They have been found in several studies to have psy-
chological benefits, lowering depression, anxiety stress, and
diabetes-distress symptoms in people with diabetes. However,
the evidence for the effectiveness of these interventions on
glycemic control is mixed. Out of the seven studies that
assessed HbA1c as a marker of glycemic control, four inter-
ventions lowered HbA1c levels, but the three largest studies
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reported no change in HbA1c [117•]. Mindfulness-based in-
tervention in diabetes is a new field, and much of the research
is exploratory. It may be that the short follow-up periods of
many studies were not sufficient to observe significant chang-
es in HbA1c.
There is limited evidence that the treatment of psychosocial
factors can reduce the risk of adverse outcomes in people with
diabetes [118]. The Prevention of Suicide in Primary Care
Elderly Collaborative Trial (PROSPECT) RCT was used to
investigate whether depression management would decrease
mortality in diabetes [119]. Depressed people with diabetes
who were assigned to the intervention group (an individual-
ized case management approach) had significantly lower mor-
tality rates than controls over a 5-year follow-up (HR 0.49;
95 % CI 0.24–0.98). However, this study has been criticized
with regards to study design and analysis, with suggestions
that the methods may not have been appropriate [120]. The
impact of mindfulness interventions on CVD outcomes in
people with diabetes has not yet been examined [117•].
In sum, there is little evidence as yet that the treatment of
psychosocial factors in diabetes has a benefit on CVD out-
comes. However, pharmacological interventions have been
shown to improve glycemic outcomes in the short term and
hyperglycemia is linearly associated with increased CVD risk
[7, 105]. Additionally, both psychological and pharmacologi-
cal treatments as well as mindfulness-based interventions ap-
pear to have beneficial effects on psychosocial factors in peo-
ple with diabetes. Despite the limited effectiveness of these
treatments on overt CVD outcomes, there have been calls that
the psychological well-being in people with diabetes should
be a priority for its own sake [121]. Since lifestyle interven-
tions have been shown to be effective for preventing diabetes,
perhaps targeting individuals before onset rather than after
diagnosis might be the optimal strategy.
Conclusion
There is an emerging body of evidence that psychological
stress factors play a role in the pathogenesis of diabetes. A
variety of negative psychosocial factors have (for the most
part) been shown to increase the risk of diabetes in initially
healthy populations. There is less research on the involvement
of psychosocial factors in CVD risk in people with existing
diabetes. To date, most of the research in this area has been on
depression, with evidence that a double diagnosis of diabetes
and depression increases the risk of CVD in this population.
Most of the studies are observational, so causal conclusions
are difficult to draw.
The mechanisms through which psychosocial stress
factors increase diabetes risk and affect outcomes in peo-
ple with existing diabetes are yet to be fully understood.
It is likely that both behavioral and biological pathways
are involved. Interventions have been shown to have a
beneficial effect on psychosocial factors in people with
diabetes, but the evidence for effects on glycemic control
is mixed, and research on interventions impacting CVD
outcomes in people with diabetes is lacking. Despite the
limited evidence for effects on physiological outcomes, it
can be argued that improving the psychological well-
being of people with diabetes should be a priority in its
own right.
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